Articles scientifiques

Efficacy of the Ad26.ZEBOV/MVA-BN-Filo Ebola vaccine regimen in a phase III trial in the DRC

Hypolite Muhindo Mavoko, Patrick Kabongo Mutombo, Marie-Claire Mukendi Ngoy, Hypo Mavoko JP, Kabongo Mutombo P, Mukendi Ngoy MC

A randomized, double-blind, placebo-controlled phase III trial evaluating the efficacy of the Ad26.ZEBOV/MVA-BN-Filo Ebola vaccine regimen among healthcare workers and at-risk populations in the Democratic Republic of the Congo.